1. BACKGROUND
=============

*Bartonella* species are intracellular bacteria capable of producing several diseases in the human host. The three most common and well-known diseases are Cat Scratch Disease (CSD), caused by *Bartonella henselae* (*B. henselae*), trench fever, caused by *Bartonella quintana* (*B. quintana*) and Carrion's Disease, caused by *Bartonella bacilliformis*. (*B. bacilliformis*) Members of the *Bartonella* genus are also capable of producing chronic bacteraemia in human hosts, bacillary angiomatosis, peliosis hepatitis, neurological disorders, endocarditis, myocarditis, retinitis and chronic lymphadenopathies. Signs and symptoms are very diverse and aspecific: fatigue, fever, headache, lymphadenopathy, malaise, and loss of weight \[[@r1]\]. No data exist to support guidelines' recommendations to decide which drugs should be optimally used and how long they should be administered \[[@r2]\]. Therefore, a marker of treatment response is needed to guide treatment strategies.

We report herein three cases in which a homemade Real-Time Polymerase Chain Reaction (RT PCR) seemed to play a fundamental role both for diagnosis and treatment monitoring.

2. MATERIALS AND METHODS
========================

We collected the serological and molecular biology data of three patients with bartonellosis followed at the outpatient clinic of Infectious and Tropical Diseases Unit of "*Mater Domini*" teaching hospital in Catanzaro (Italy). We compared, in particular, the concordance of serological test results (IgG and IgM for *B. henselae*) with the result of real-time PCR, and clinical outcome after therapy.

*B. henselae* IgG and IgM were tested by indirect fluorescent antibody analysis (Euroimmun, Medizinische Labordiagnostika AG, Germany) using a IgG titre ≥1:64 and IgM titre ≥1:20 as cut-off, according to the manufacturer's instruction.

A homemade real-time PCR with SYBR Green 1 dye was performed as previously described \[[@r3], [@r4]\]. Briefly, DNA extraction from whole blood was carried out using the QIAamp DNA Blood Mini Kit (QIAGEN^®^ Group) according to the manufacturer's instruction. Two μl of extracted DNA (20 ng) were used for the amplification by real-time PCR with SYBR Green 1 dye using a pair of primers (Forward 5'-TTGCGACAAAACAGCTTCAC-3\' and Reverse 5'-GATGGAGCATCTGCACTCAA-3'), which amplify a 510 bp region of the *bqtR* gene. *B. henselae* melting temperature (Tm) was 87.39±0.20° C. We amplified a 510 bp fragment of the *bqtR* gene because it was able to distinguish *B. quintana* and *B. henselae* strains by melting temperature. The melting temperatures were significantly (P\<0.05) different, therefore allowing us to discriminate the two species (3,4). Amplification and melting curve of *B. henselae* can be seen in Fig. (**[1](#F1){ref-type="fig"}**).

Diagnostic workup was completed with RT PCR as soon as we received positive results of IgG for *Bartonella*. Therapy was started as soon as patients were contacted and came back to consultation after receiving positive RT PCR.

3. CASE REPORTS {#sec3}
===============

3.1. Case Report \#1 (Table **[1](#T1){ref-type="table"}**)
-----------------------------------------------------------

A 42 years-old Caucasian male (weight: 84 kg, height: 178 cm), came to our observation in July 2013 complaining about asthenia associated with a right latero-cervical lymphadenomegaly, started two years before. The patient, along with these symptoms, has never reported fever. He was resident in a rural area, living in contact with several animals (in particular birds and cats) and worked as a volunteer in a human hospital. The patient reported allergy to diclofenac, *cipressaceae* and *parietaria* plants. He underwent two interventions for inguinal hernia, the first at the age of 11 years and the second at the age of 34. In 2004, he suffered from kidney stones. In 2004 he had toxoplasmosis. In July and in August 2014 he was referred twice to the Unit of Neurology because of a previous diagnosis of epilepsy treated with levetiracetam and topiramate from 2002 to 2007. Upon admission to the neurology ward, serological tests for several agents were performed (*T. gondii*, *Cytomegalovirus*, Epstein-Barr virus, *Brucella*, HBV, HCV, HIV, *T. pallidum*, *Salmonella* spp.), and all were negative. Full blood cell count was normal. Lymph node ultrasound (US) documented the presence of numerous lymph nodes at submandibular, lateral cervical, axillary and groin regions with maximum diameter of about 2.5 cm. So, we decided to perform both serology and RT PCR for *Bartonella spp*., for the suspicion of CSD. The result of a positive RT PCR for *B. henselae* led us to star therapy with doxycycline 100 mg, twice daily, *per os* for ten days. Then the patient discontinued treatment for epigastralgia. After 9 days, he restarted doxycycline 100 mg, twice daily, *per os*. We suggested him, in order to avoid further epigastralgia, to take a gastroprotective therapy, so he was able to continue an appropriate treatment for two weeks. This therapy was stopped after RT PCR for *B. henselae* DNA resulted to be undetectable. After antibiotic therapy, there was a significant reduction of lymphadenopathy and fatigue and asthenia recovered. At the last outpatient consultation, in June 2014, just a small left later cervical node was evident, followed by complete regression in January 2015.

3.2. Case Report \#2 (Table **[2](#T2){ref-type="table"}**)
-----------------------------------------------------------

A 69 years-old female, with hypercholesterolemia on treatment, came to our observation in August 2013 for right axillary lymphadenopathy just started, associated with recurrent fever, chilling and malaise. These symptoms appeared 4 months before. She lived, like patient \#1, in a rural area and was in contact with cats and rabbits in her countryside village. Full blood cell count was normal. Also in this case serologies for several infections were performed (*T. gondii*, *Cytomegalovirus*, Epstein-Barr virus, *Brucella*, HBV, HCV, HIV, *T. pallidum*, *Salmonella* spp.), and all were negative. Furthermore, both serology and RT PCR for *Bartonella* spp. were performed. In particular, IgG were positive (with 1:320 titre), IgM were negative and RT PCR for *B. henselae* DNA was positive. Chest X-ray did not show any abnormalities. Lymph node US revealed an enlarged lymph node in the right axilla with thickened cortical region with a size of 1.5 x 1 cm. So, in addition to the serological tests, the patient underwent incomplete removal of the axillary lymph node that appeared partially necrotic. Histopathological examination of the lymph node showed: "Granulomatous lymphadenitis in epithelioid cells with florid hyperplasia and areas of necrosis". After biopsy, drainage of purulent material persisted. The patient started a treatment with intravenous (IV) gentamicin 80 milligrams three times per day for a week in addition to IV ceftriaxone 2 g *per* day for a week, then continued treatment with doxycyclin 100 mg *per os* twice daily for 6 weeks. At the last check, the patient reported well-being, no fever and just a residual pain at the site of the biopsy.

3.3. Case Report \#3 (Table **[3](#T3){ref-type="table"}**)
-----------------------------------------------------------

A 35 years-old Caucasian male, smoker and working as a bricklayer, was living in contact with different animals (cats, dogs and parrots). He came to our observation for asthenia, lymphadenopathy in left axillary region, arthralgia and low-grade fever in the evening, lasting for two months. He referred many cat scratches from his cats and many insect bites four months before symptom begun. Serological tests for several agents appeared to be negative (*T. gondii*, *Cytomegalovirus*, Epstein-Barr virus, *Brucella* species, HBV, HCV, HIV, *T. pallidum*, *Salmonella* spp). Full blood cell count was normal. Chest X-ray did not show any abnormalities. Lymph node US documented four lymph nodes at left axillary region with thickened wall, with diameters ranged from 1.8 to 3.5 cm. Also, many and small lymph nodes were found in submandibular, lateral cervical and groin regions. We decided to perform both serology and RT PCR for *Bartonella* spp. with the suspicion of CSD, finding positive IgG, IgM and RT PCR for *B. henselae*. So we administered IV ceftriaxone 1 g daily for a week and doxycyclin 100 mg twice daily *per os* for 6 weeks. After the first two weeks of treatment, symptoms disappeared and the patient referred well-being status. Also, in this case, RT PCR was useful for two reasons: firstly to evaluate if positivity was present, secondly to evaluate the efficacy of treatment in order to evaluate therapy interruption.

4. DISCUSSION {#sec4}
=============

Clinical evolutions of diseases due to *Bartonella species* are diverse depending on bacterial species and status of the immune system of the host. In fact, infections can be mild or asymptomatic in immunocompetent hosts or severe in the immunocompromised hosts \[[@r5]\]. Moreover, no clinical trials or databases of clinical studies with standard case definitions, microbiological confirmation through culture, and rigidly defined disease outcomes are available. For these reasons, therapy indications are based only on case reports with a very limited number of subjects enrolled \[[@r1], [@r2]\]. In particular, treatment is not standardized, both for type of drugs and duration of therapy \[[@r2]\]. Indeed, few studies evaluated antibiotic schemes for CSD and chronic bacteriaemia \[[@r8]\]. For this reason, we tried to tailor therapy based on clinical pictures of individual patients.

For instance, case \#2 was the most severe, so we added ceftriaxone to gentamicin and doxycycline for additive or synergistic effect. Such strategy appeared to be successful over a short-term follow-up as demonstrated by sustained undetectability of *Bartonella* DNA.

Since *Bartonella* are intracellular bacteria, their isolation through culture is very difficult and slow, even on cell systems \[[@r6]\]. So, bartonelloses are often diagnosed through serological tests. However, these tests can be negative since the conventional anti-*Bartonella henselae* IgM ELISA methods are poor for as far as both sensitivity and specificity are concerned \[[@r7]\]. In line with data showing that serology is affected by false negative results, among our patients, only 1 out of 3 had positive IgM, while Bartonella DNA was positive in all cases. On the other hand, it should be considered that the examined patients showed clinical signs started long time before, so it is not unusual to obtain negative IgM because this kind of antibodies may have already disappeared. By contrast, if IgM had disappeared, IgG were positive in all examined cases, a result concordant with the positivity of RT PCR. Moreover, not only RT PCR was useful for diagnostic purposes, but also helped significantly for treatment monitoring and decisions regarding therapy continuation or interruption. Indeed, even if drug regimens were heterogeneous because they were tailored according to the severity of the clinical picture, RT PCR was consistent with the clinical course of patients, indicating to stop therapy after *Bartonella* DNA was found to be persistently negative. Given the lack of precise standards for treatment, this potential of RT PCR merits to be emphasized to clinicians.

CONCLUSION
==========

In conclusion, this case series indicated the utility of molecular identification and quantification of *Bartonellae* spp. infections with species-specific RT PCR both for diagnosis and monitoring of treatment response. Further studies are necessary to validate these results and elucidate what is the best treatment for this pleomorphic disease.
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###### 

Laboratory and clinical course of patient \#1.

  ------------------------------------------------------------------------------------------------------------------------------------------
  Date                    IgG\        IgM\       RT PCR\    Therapy                                      Signs or Symptoms
                          (titres)    (titres)   DNA                                                     
  ----------------------- ----------- ---------- ---------- -------------------------------------------- -----------------------------------
  July, 24^th^ 2013       Positive\   Negative   Not done   No therapy                                   Asthenia, lymphadenopathy
                          1:320                                                                          

  October, 31^rst^ 2013   Positive\   Negative   Positive   No therapy                                   Asthenia, lymphadenopathy
                          1:320                                                                          

  February, 11^th^ 2014   Positive\   Negative   Positive   Doxycycline 100 mg twice daily, *per os,*\   Asthenia, lymphadenopathy
                          1:320                             for ten days                                 

  March, 12^th^ 2014      Not done    Not done   Positive   Doxycycline 100 mg twice daily, *per os,*\   Asthenia, lymphadenopathy
                                                            for two weeks                                

  April, 16^th^ 2014      Not done    Not done   Negative   Doxycycline 100 mg twice daily, *per os,*\   Lymphadenopathy
                                                            for two weeks                                

  May, 13^th^ 2014        Not done    Not done   Negative   No therapy                                   Small center latero-cervical node

  June, 9^th^ 2014        Not done    Not done   Negative   No therapy                                   Small center latero-cervical node

  January, 27^th^ 2015    Not done    Not done   Negative   No therapy                                   No signs or symptoms
  ------------------------------------------------------------------------------------------------------------------------------------------

###### 

Laboratory and clinical course of patient \#2.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Date                    IgG\        IgM\       RT PCR     Therapy                                       Signs or Symptoms
                          (titres)    (titres)                                                            
  ----------------------- ----------- ---------- ---------- --------------------------------------------- --------------------------------------------------------
  August, 7^th^ 2013      Positive\   Negative   Not done   No therapy                                    Lymphadenopathy, recurrent fever, chilling and malaise
                          1:320                                                                           

  October, 29^th^ 2013    Positive\   Negative   Positive   No therapy                                    Lymphadenopathy, recurrent\
                          1:320                                                                           fever, chilling and malaise

  December, 10^th^ 2013   Not done    Not done   Positive   Gentamicin 80 mg three times *per* day IV,\   Lymphadenopathy, recurrent fever, chilling and malaise
                                                            and\                                          
                                                            Ceftriaxone 1 g twice daily IV, for a week\   
                                                            and\                                          
                                                            Doxycycline 100 mg twice daily, *per os,*\    
                                                            for six weeks                                 

  December, 20^th^ 2013   Not done    Not done   Negative   Doxycycline 100 mg twice daily, *per os,*\    Lymphadenopathy
                                                            for four weeks and four days                  

  January, 29^th^ 2014    Positive\   Negative   Negative   No therapy                                    No signs or symptoms
                          1:320                                                                           

  March, 4^th^ 2014       Not done    Not done   Negative   No therapy                                    No signs or symptoms
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Laboratory and clinical course of patient \#3.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Date                    IgG\        IgM\       RT PCR     Therapy                                       Signs or Symptoms
                          (titres)    (titres)                                                            
  ----------------------- ----------- ---------- ---------- --------------------------------------------- ------------------------------------------------------------
  October, 17^th^ 2014    Positive\   Positive   Positive   Ceftriaxone 1 g twice daily IV, for a week\   Lymphadenopathy, arthralgia, asthenia, and low-grade fever
                          1:320                             and\                                          
                                                            Doxycycline 100 mg twice daily, *per os,*\    
                                                            for six weeks                                 

  December, 12^th^ 2014   Not done    Not done   Negative   No therapy                                    No signs or symptoms
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
